SEARCH

SEARCH BY CITATION

Appendix S1. Full figure legends for the below.

Figure S1. Sensitivity of transformed Ercc1-proficient and Ercc1-deficient melanocytes to chemotherapeutics.

Figure S2. DNA content of cisplatin-treated transformed Ercc1-proficient and Ercc1-deficient melanocytes.

Figure S3. Cisplatin-induced apoptosis in transformed Ercc1-proficient and Ercc1-deficient melanocytes.

Figure S4.Ercc1 expression in transformed Ercc1-proficient melanocytes following cisplatin treatment.

Table S1. Cell cycle analysis of cisplatin-treated transformed Ercc1-proficient and Ercc1-deficient melanocytes.

Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

FilenameFormatSizeDescription
PCMR_882_sm_AppS1.pdf45KSupporting info item
PCMR_882_sm_FigS1.tif168KSupporting info item
PCMR_882_sm_FigS2.tif364KSupporting info item
PCMR_882_sm_FigS3.tif4091KSupporting info item
PCMR_882_sm_FigS4.tif908KSupporting info item
PCMR_882_sm_TableS1.pdf10KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.